SciELO - Scientific Electronic Library Online

 
vol.92 número3Ablación de taquicardia ventricular asistida con ECMO. Primera experiencia en nuestra instituciónRelación entre la disbiosis de la microbiota oral y la enfermedad cardiovascular aterosclerótica índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Archivos de cardiología de México

versão On-line ISSN 1665-1731versão impressa ISSN 1405-9940

Resumo

ARELLANO-BUENDIA, Abraham S. et al. Molecular mechanisms of the beneficial effects of allicin on cardiovascular disease. Arch. Cardiol. Méx. [online]. 2022, vol.92, n.3, pp.362-370.  Epub 08-Ago-2022. ISSN 1665-1731.  https://doi.org/10.24875/acm.21000196.

Cardiovascular diseases (CVD) include a group of diseases whose common denominator is the affection of the blood vessels, heart, and heart rate. The treatment of CVD represents high costs to the health systems and is focused on the control of risk factors. Despite the existence of a great variety of treatments of the CVD, these continue as the main cause of mortality mainly due to the multifactorial origin, and therefore more than one drug is required. In this context, allicin, a compound derived from garlic, has shown regulate the expression of signaling pathways and risk factors associated with the progression of CVD. Therefore, the objective of this work is to review the cellular and molecular mechanisms through which allicin exert its therapeutic effects and to describe the scientific evidences why allicin represents a potential candidate to assist in the treatment of CVD.

Palavras-chave : Allicin; Cardiovascular disease; Risk factors; Molecular mechanisms.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )